AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection

Aksyuk, AA; Bansal, H; Wilkins, D; Stanley, AM; Sproule, S; Maaske, J; Sanikommui, S; Hartman, WR; Sobieszczyk, ME; Falsey, AR; Kelly, EJ

Kelly, EJ (通讯作者),AstraZeneca, Translat Med Vaccines & Immune Therapies, BioPharmaceut R&D, Gaithersburg, MD 20878 USA.;Falsey, AR (通讯作者),Univ Rochester, Sch Med & Dent, Rochester, NY 14642 USA.;Falsey, AR (通讯作者),Rochester Reg Hlth, Rochester, NY 14621 USA.

CELL REPORTS MEDICINE, 2023; 4 (1):

Abstract

The nasal mucosa is an important initial site of host defense against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. However,......

Full Text Link